The Zeeuws Investment Fund (Zeeuws Investeringsfonds, or ZIF) invests an undisclosed amount in Deventer based Dovideq Medical, developer of testing devices for endoscopes.
Dovideq has created ScopeControl, a device that measures the quality of endoscopes (you know, those little tubes with a camera entering your body), and objectively assesses whether an endoscope can be used in the operating room.
Next to that the medtech startup created a scanner for medical instruments which can be used for track and trace purposes, and a cloud environments where all data (like measurements) of endoscopes are saved.
A lot of surgeries performed are so-called keyhole surgeries, in which endoscopes are used. Unfortunately a lot of hospitals suffer from defective endoscopes, which results in delays during surgery but also creates a higher risk for the patient.
Typical clients of Dovideq are hospitals, sterilisation companies, manufacturers and repairers. It has distributors all over the world.
Dovideq world domination
“With the funding we want to become a leading player in the field of control and optimal usage of endoscopes within 5 years”, says Bert Dommerholt, co-founder and CEO of Dovideq.
The seed funding is used to grow internationally and make new product developments. Johan Sebregts, fund manager of ZIF was impressed with the performance of the company. “They had already sold a sizeable number of ScopeControls to leading hospitals, created ties with some renowned distributors and were supported in the development by researchers and specialist in both The Netherlands and Germany.”
Although Sebregts couldn’t disclose the exact amount of funding to StartupJuncture, ZIF usually invests 400.000 euro to 1 million euro, so “somewhere in the middle would be a safe neutral bet”.